One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

(MedPage Today) — Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort study suggested…

Source link : https://www.medpagetoday.com/ophthalmology/glaucoma/118988

Author :

Publish date : 2025-12-13 13:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Florida Plows Ahead on Push to Roll Back Certain Vaccine Mandates for Schoolchildren

Related Posts

More GLP-1 Drug Lawsuits; Military’s Rising Obesity Rates; Male Birth Control Soon?

Can Women Get Far Fewer Cervical Cancer Screenings After HPV Vaccination?

Travel Help Announced for Families of Children With Cancer

A ‘Vicious Cycle’: How Nursing Shortage Could Worsen Under Trump Team’s Plan

If Trader Joe’s Ran Your Hospital

Is Assisted Death Always Peaceful? We Simply Don’t Know

More GLP-1 Drug Lawsuits; Military’s Rising Obesity Rates; Male Birth Control Soon?

Can Women Get Far Fewer Cervical Cancer Screenings After HPV Vaccination?

Travel Help Announced for Families of Children With Cancer

A ‘Vicious Cycle’: How Nursing Shortage Could Worsen Under Trump Team’s Plan

If Trader Joe’s Ran Your Hospital

Is Assisted Death Always Peaceful? We Simply Don’t Know

Which Fibromyalgia Drug Offers the Best Value?

Seven million cancers a year are preventable, says report

Categories

Archives